INVENTIVA ADS/1 O.N. - Asset Resilience Ratio

Latest as of December 2025: 52.73%

INVENTIVA ADS/1 O.N. (6IVA) has an Asset Resilience Ratio of 52.73% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€131.56 Million

≈ $153.81 Million USD Cash + Short-term Investments

Total Assets

€249.51 Million

≈ $291.70 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how INVENTIVA ADS/1 O.N.'s Asset Resilience Ratio has changed over time. Check INVENTIVA ADS/1 O.N. (6IVA) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down INVENTIVA ADS/1 O.N.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see INVENTIVA ADS/1 O.N. market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€131.56 Million	52.73%
Total Liquid Assets	€131.56 Million	52.73%

Asset Resilience Insights

Very High Liquidity: INVENTIVA ADS/1 O.N. maintains exceptional liquid asset reserves at 52.73% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

INVENTIVA ADS/1 O.N. Industry Peers by Asset Resilience Ratio

Compare INVENTIVA ADS/1 O.N.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for INVENTIVA ADS/1 O.N. (2021–2025)

The table below shows the annual Asset Resilience Ratio data for INVENTIVA ADS/1 O.N..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	52.73%	€131.56 Million ≈ $153.81 Million	€249.51 Million ≈ $291.70 Million	--
2024-12-31	0.00%	€0.00 ≈ $0.00	€118.97 Million ≈ $139.08 Million	--
2023-12-31	0.10%	€70.00K ≈ $81.84K	€69.56 Million ≈ $81.32 Million	-0.80pp
2022-12-31	0.90%	€1.05 Million ≈ $1.23 Million	€116.00 Million ≈ $135.62 Million	-6.33pp
2021-12-31	7.24%	€8.83 Million ≈ $10.32 Million	€121.98 Million ≈ $142.61 Million	--

pp = percentage points

About INVENTIVA ADS/1 O.N.

F:6IVA Germany Biotechnology

Market Cap

$982.79 Million

€840.63 Million EUR

Market Cap Rank

#8988 Global

#1160 in Germany

Share Price

€4.38

Change (1 day)

-0.45%

52-Week Range

€2.56 - €6.00

All Time High

€15.60